Maria Globan

Maria Globan

Auto-generated profile, based on publicly available information

Maria Globan

Mycobacterium Reference Laboratory, Victorian Infectious Diseases Laboratory, at The Peter Doherty Institute for Infection & Immunity

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2022 in Journal of Medical Microbiology
Verified
Journal Article
Open access
KYKim Yeoh
Kim Yeoh
MGMaria Globan
Maria Globan
PNPhillip Naimo
Phillip Naimo
DWDeborah A. Williamson
Deborah A. Williamson
KLKerrie Lea
Kerrie Lea
KBKatherine Bond
Katherine Bond
Introduction. Nocardia is an opportunistic pathogen that can cause significant morbidity and mortality, particularly in the immunocompromised host. Antimicrobial susceptibility profiles vary across Nocardia spp. and vary within Australia as well as worldwide. Knowledge of local susceptibility patterns is important in informing appropriate empiric antimicrobial therapy. Gap Statement. This is the largest study to date in Australia that correlates antimicrobial susceptibility profiles with molecular identification of Nocardia species. It is the first study that examines isolates from multiple institutions across the state of Victoria, Australia. Aim. To investigate the species distribution and antibiotic susceptibility of Nocardia spp. isolates referred to the Mycobacterial Reference Laboratory (MRL) in Victoria, Australia from 2009 to 2019. Methodology. We conducted a retrospective review of Nocardia spp. isolates which were identified using molecular sequencing. Antimicrobial susceptibility testing was performed using standardized broth microdilution method with Sensititre RAPMYCO1 plates. Species distribution and antibiotic susceptibility profiles were analysed. Results. In total, 414 Nocardia isolates were identified to 27 species levels, the majority originating from the respiratory tract (n=336, 81.2 %). N. nova (n=147, 35.5 %) was the most frequently isolated, followed by N. cyriacigeorgica (n=75, 18.1 %). Species distribution varied by isolate source, with N. farcinica and N. paucivorans found more commonly from sterile sites. Linezolid and amikacin had the highest proportion of susceptible isolates (100 and 99% respectively), while low susceptibility rates were detected for ceftriaxone (59 %) and imipenem (41 %). Susceptibility to trimethoprim sulfamethoxazole varied by species (0–100 %). Conclusion. This is the largest study to date in Australia of Nocardia species distribution and antimicrobial susceptibility patterns. N. farcinica and N. paucivorans were more likely to be isolated from sterile sites, while N. brasiliensis and N. otitidiscvarium were more likely to be isolated from skin and soft tissue. First line therapeutic antimicrobial recommendations by local guidelines were not necessarily reflective of the in vitro susceptibility of Nocardia isolates in this study, with high susceptibility detected for linezolid and amikacin, but poor susceptibility demonstrated for ceftriaxone and imipenem. Profiles for trimethoprim-sulfamethoxazole varied across different Nocardia species, warranting ongoing susceptibility testing for targeted clinical use.

6 November 2015 in Microbial Genomics
Verified
Journal Article
Open access
EMElla Meumann
Ella Meumann
MGMaria Globan
Maria Globan
JFJanet A. M. Fyfe
Janet A. M. Fyfe
DLDavid Leslie
David Leslie
JPJessica L. Porter
Jessica L. Porter
TSTimothy Stinear
Timothy Stinear
We report a case of chronic pulmonary multi-drug-resistant tuberculosis. Despite 14 years of treatment, Mycobacterium tuberculosis was persistently isolated from sputum. Following treatment cessation the patient remained well, although M. tuberculosis was isolated from sputum for a further 8 years. Genome sequencing of eight serial M. tuberculosis isolates cultured between 1991 and 2011 revealed 17 mutations (0.8 mutations per genome year− 1). Eight of these were persisting mutations and only two mutations were detected in the 7 years following cessation of treatment in 2004. In four isolates there were mixed alleles, suggesting the likely presence of bacterial subpopulations. The initial 1991 isolate demonstrated genotypic resistance to isoniazid (katG W91R), rifampicin (rpoB S531L), ethambutol (embB M306V), streptomycin (gidB L16R), quinolones (gyrA S95T) and P-aminosalicylic acid (thyA T202A). Subsequent resistance mutations developed for pyrazinamide (pncA I31F) and ethionamide (ethA frameshift). Such information might have been instructive when developing a treatment regimen. In retrospect and with the benefit of high-resolution genomic hindsight we were able to determine that the patient received only one or two active anti-tuberculous agents for most of their treatment. Additionally, mutations in bacA and Rv2326c were detected, which may have contributed to the persistent but mild disease course. BacA is likely to be associated with maintenance of chronic infection and Rv2326c with a decreased bacterial metabolic state. These results expand our understanding of M. tuberculosis evolution during human infection and underline the link between antibiotic resistance and clinical persistence.

3 May 2024 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
SMStephen Muhi
Stephen Muhi
ABAndrew H Buultjens
Andrew H Buultjens
JPJessica L Porter
Jessica L Porter
JMJulia L Marshall
Julia L Marshall
MDMarcel Doerflinger
Marcel Doerflinger
TSTimothy Stinear
Timothy Stinear
Critical scientific questions remain regarding infection with Mycobacterium ulcerans, the organism responsible for the neglected tropical disease, Buruli ulcer (BU). A controlled human infection model has the potential to accelerate our knowledge of the immunological correlates of disease, to test prophylactic interventions and novel therapeutics. Here we present microbiological evidence supporting M. ulcerans JKD8049 as a suitable human challenge strain. This non-genetically modified Australian isolate is susceptible to clinically relevant antibiotics, can be cultured in animal-free and surfactant-free media, can be enumerated for precise dosing, and has stable viability following cryopreservation. Infectious challenge of humans with JKD8049 is anticipated to imitate natural infection, as M. ulcerans JKD8049 is genetically stable following in vitro passage and produces the key virulence factor, mycolactone. Also reported are considerations for the manufacture, storage, and administration of M. ulcerans JKD8049 for controlled human infection.

23 December 2025 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
ABAndrew H. Buultjens
Andrew H. Buultjens
KVKoen Vandelannoote
Koen Vandelannoote
JPJessica L. Porter
Jessica L. Porter
SMStephen Muhi
Stephen Muhi
EHEmma C. Hobbs
Emma C. Hobbs
TSTimothy Stinear
Timothy Stinear
Buruli ulcer in southeastern Australia is a zoonosis caused by infection with Mycobacterium ulcerans . Australian native possums are a major wildlife reservoir, and infected possums shed M. ulcerans in their excreta, with mosquitoes being the major transmitting vector in this region. Buruli ulcer is geographically restricted, and this feature, combined with an average 4.8-month incubation period, makes tracking M. ulcerans environmental spread and timely identification of new Buruli ulcer endemic areas challenging. While human mobility complicates transmission tracing, we used the highly territorial behavior of native possums and high-resolution pathogen genomics to confidently identify new Buruli ulcer endemic areas in Melbourne’s inner northwest and southern suburbs of Geelong. Using pathogen genomic phylodynamic modeling, we estimated that M. ulcerans was introduced to these areas 2–6 years before the emergence of human Buruli ulcer cases. This study shows how possum excreta surveys combined with pathogen genome data can pinpoint new Buruli ulcer endemic areas, thus providing critical local knowledge for targeted public health interventions to reduce exposure risk and ensure early diagnosis. IMPORTANCE: Buruli ulcer is a debilitating skin disease caused by Mycobacterium ulcerans , with transmission in southeastern Australia involving native possums as wildlife reservoirs and mosquitoes as vectors. Early detection of new endemic areas is critical to preventing human disease, yet is hindered by the pathogen’s long incubation period, highly focal transmission, and the mobility of human hosts. This study demonstrates how structured possum excreta surveys, combined with high-resolution pathogen genomics, can confidently identify new Buruli ulcer endemic areas in southeastern Australia. By confirming local transmission in Melbourne’s inner northwest and Geelong through genome matching between possum- and human-derived M. ulcerans , we provide a framework for targeted, timely public health interventions. This integrated wildlife-environment-human approach exemplifies the power of One Health surveillance to detect and manage emerging zoonotic threats, offering a scalable model for other regions where Buruli ulcer is endemic.

30 July 2025 in bioRxiv
Verified
Preprint
Open access
ABAndrew H. Buultjens
Andrew H. Buultjens
KVKoen Vandelannoote
Koen Vandelannoote
JPJessica L. Porter
Jessica L. Porter
SMStephen Muhi
Stephen Muhi
EHEmma C. Hobbs
Emma C. Hobbs
TSTimothy Stinear
Timothy Stinear
Buruli ulcer (BU) in southeastern Australia is a zoonosis caused by infection with Mycobacterium ulcerans . Australian native possums are a major wildlife reservoir and infected possums shed M. ulcerans in their excreta, with mosquitoes being the major transmitting vector in this region. BU is geographically restricted and this feature, combined with an average 4.8-month incubation period, makes tracking M. ulcerans environmental spread and timely identification of new BU endemic areas challenging. While human movement complicates transmission tracing, we used the highly territorial behaviour of native possums and high-resolution pathogen genomics to confidently identify new BU endemic areas in Melbourne’s inner northwest and southern suburbs of Geelong. Using pathogen genomic phylodynamic modelling, we estimated that M. ulcerans was introduced to these areas 2-6 years before the emergence of human BU cases. This study shows how possum excreta surveys combined with pathogen genome data can pinpoint new BU endemic areas, thus providing critical local knowledge for targeted public health interventions to reduce exposure risk and ensure early diagnosis.

10 September 2026 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
DWDaisy Wang
Daisy Wang
AFAngeline Ferdinand
Angeline Ferdinand
Justin DenholmJustin Denholm
Justin Denholm
KDKatie Dale
Katie Dale
SBSimone Bittmann
Simone Bittmann
MKMartyn D. Kirk
Martyn D. Kirk
Whole Genome Sequencing (WGS) is increasingly being used to enhance tuberculosis (TB) surveillance and management. However, evidence on how WGS shapes real-world decision-making remains limited. This study explored the utility of WGS in the context of a TB outbreak in Victoria, Australia. We conducted a case study to (1) describe a TB outbreak in Victoria using epidemiological and genomic data and (2) explore the perceived benefits and limitations of WGS through qualitative interviews with laboratory and public health professionals involved in the investigation. The interviews were analysed thematically. From 2017 – 2023, 36 people were linked to a large lineage 4 TB outbreak comprising 3 sub-clusters. WGS connected two patients who were initially not epidemiologically linked to the outbreak, prompting additional contact screening at a medical clinic. From interviews with 10 laboratory and public health professionals, WGS was considered a useful tool, although there was a gap between its potential and realised utility. WGS strengthened confidence in suspected transmission links, which was particularly valuable when epidemiological evidence was sparce or uncertain. This was relevant in this investigation where TB stigma, a prolonged timeframe, and cross-jurisdictional transmission were challenges. Barriers to public health action from WGS included long turnaround times, difficulties drawing conclusions from identical isolates, and uncertainties around public health follow-up actions. This case study demonstrates that WGS can inform meaningful public health action, while also identifying opportunities to improve its utility. WGS for public health should involve real-time sequencing along with steps to support the translation of findings into actions such as action-focused WGS training, mechanisms to support consistent follow-up, and improved record-keeping systems.